An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program

Gerald Cochran, Adam J. Gordon, Wei Hsuan Lo-Ciganic, Walid F. Gellad, Winfred Frazier, Carroline Lobo, Chung Chou H. Chang, Ping Zheng, Julie M. Donohue

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Health systems may play an important role in identification of patients at-risk of opioid medication overdose. However, standard measures for identifying overdose risk in administrative data do not exist. Objective: Examine the association between opioid medication overdose and 2 validated measures of nonmedical use of prescription opioids within claims data. Research Design: A longitudinal retrospective cohort study that estimated associations between overdose and nonmedical use. Subjects: Adult Pennsylvania Medicaid program 2007-2012 patients initiating opioid treatment who were: nondual eligible, without cancer diagnosis, and not in long-term care facilities or receiving hospice. Measures: Overdose (International Classification of Disease, ninth edition, prescription opioid poisonings codes), opioid abuse (opioid use disorder diagnosis while possessing an opioid prescription), opioid misuse (a composite indicator of number of opioid prescribers, number of pharmacies, and days supplied), and dose exposure during opioid treatment episodes. Results: A total of 372,347 Medicaid enrollees with 583,013 new opioid treatment episodes were included in the cohort. Opioid overdose was higher among those with abuse (1.5%) compared with those without (0.2%, P<0.001). Overdose was higher among those with probable (1.8%) and possible (0.9%) misuse compared with those without (0.2%, P<0.001). Abuse [adjusted rate ratio (ARR), 1.52; 95% confidence interval (CI), 1.10-2.10), probable misuse (ARR, 1.98; 95% CI, 1.46-2.67), and possible misuse (ARR, 1.76; 95% CI, 1.48-2.09) were associated with significantly more events of opioid medication overdose compared with those without. Conclusions: Claims-based measures can be used by health systems to identify individuals at-risk of overdose who can be targeted for restrictions on opioid prescribing, dispensing, or referral to treatment.

Original languageEnglish (US)
Pages (from-to)291-298
Number of pages8
JournalMedical Care
Volume55
Issue number3
DOIs
StatePublished - 2017
Externally publishedYes

Fingerprint

Medicaid
Opioid Analgesics
Prescriptions
Confidence Intervals
Hospices
Pharmacies
Health
Long-Term Care
International Classification of Diseases
Therapeutics
Poisoning

Keywords

  • health claims
  • opioid medication misuse and abuse
  • opioid medication overdose

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Cochran, G., Gordon, A. J., Lo-Ciganic, W. H., Gellad, W. F., Frazier, W., Lobo, C., ... Donohue, J. M. (2017). An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program. Medical Care, 55(3), 291-298. https://doi.org/10.1097/MLR.0000000000000676

An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program. / Cochran, Gerald; Gordon, Adam J.; Lo-Ciganic, Wei Hsuan; Gellad, Walid F.; Frazier, Winfred; Lobo, Carroline; Chang, Chung Chou H.; Zheng, Ping; Donohue, Julie M.

In: Medical Care, Vol. 55, No. 3, 2017, p. 291-298.

Research output: Contribution to journalArticle

Cochran, G, Gordon, AJ, Lo-Ciganic, WH, Gellad, WF, Frazier, W, Lobo, C, Chang, CCH, Zheng, P & Donohue, JM 2017, 'An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program', Medical Care, vol. 55, no. 3, pp. 291-298. https://doi.org/10.1097/MLR.0000000000000676
Cochran, Gerald ; Gordon, Adam J. ; Lo-Ciganic, Wei Hsuan ; Gellad, Walid F. ; Frazier, Winfred ; Lobo, Carroline ; Chang, Chung Chou H. ; Zheng, Ping ; Donohue, Julie M. / An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program. In: Medical Care. 2017 ; Vol. 55, No. 3. pp. 291-298.
@article{28ca5537e27f4aefb8adb68b18779b1a,
title = "An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program",
abstract = "Background: Health systems may play an important role in identification of patients at-risk of opioid medication overdose. However, standard measures for identifying overdose risk in administrative data do not exist. Objective: Examine the association between opioid medication overdose and 2 validated measures of nonmedical use of prescription opioids within claims data. Research Design: A longitudinal retrospective cohort study that estimated associations between overdose and nonmedical use. Subjects: Adult Pennsylvania Medicaid program 2007-2012 patients initiating opioid treatment who were: nondual eligible, without cancer diagnosis, and not in long-term care facilities or receiving hospice. Measures: Overdose (International Classification of Disease, ninth edition, prescription opioid poisonings codes), opioid abuse (opioid use disorder diagnosis while possessing an opioid prescription), opioid misuse (a composite indicator of number of opioid prescribers, number of pharmacies, and days supplied), and dose exposure during opioid treatment episodes. Results: A total of 372,347 Medicaid enrollees with 583,013 new opioid treatment episodes were included in the cohort. Opioid overdose was higher among those with abuse (1.5{\%}) compared with those without (0.2{\%}, P<0.001). Overdose was higher among those with probable (1.8{\%}) and possible (0.9{\%}) misuse compared with those without (0.2{\%}, P<0.001). Abuse [adjusted rate ratio (ARR), 1.52; 95{\%} confidence interval (CI), 1.10-2.10), probable misuse (ARR, 1.98; 95{\%} CI, 1.46-2.67), and possible misuse (ARR, 1.76; 95{\%} CI, 1.48-2.09) were associated with significantly more events of opioid medication overdose compared with those without. Conclusions: Claims-based measures can be used by health systems to identify individuals at-risk of overdose who can be targeted for restrictions on opioid prescribing, dispensing, or referral to treatment.",
keywords = "health claims, opioid medication misuse and abuse, opioid medication overdose",
author = "Gerald Cochran and Gordon, {Adam J.} and Lo-Ciganic, {Wei Hsuan} and Gellad, {Walid F.} and Winfred Frazier and Carroline Lobo and Chang, {Chung Chou H.} and Ping Zheng and Donohue, {Julie M.}",
year = "2017",
doi = "10.1097/MLR.0000000000000676",
language = "English (US)",
volume = "55",
pages = "291--298",
journal = "Medical Care",
issn = "0025-7079",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program

AU - Cochran, Gerald

AU - Gordon, Adam J.

AU - Lo-Ciganic, Wei Hsuan

AU - Gellad, Walid F.

AU - Frazier, Winfred

AU - Lobo, Carroline

AU - Chang, Chung Chou H.

AU - Zheng, Ping

AU - Donohue, Julie M.

PY - 2017

Y1 - 2017

N2 - Background: Health systems may play an important role in identification of patients at-risk of opioid medication overdose. However, standard measures for identifying overdose risk in administrative data do not exist. Objective: Examine the association between opioid medication overdose and 2 validated measures of nonmedical use of prescription opioids within claims data. Research Design: A longitudinal retrospective cohort study that estimated associations between overdose and nonmedical use. Subjects: Adult Pennsylvania Medicaid program 2007-2012 patients initiating opioid treatment who were: nondual eligible, without cancer diagnosis, and not in long-term care facilities or receiving hospice. Measures: Overdose (International Classification of Disease, ninth edition, prescription opioid poisonings codes), opioid abuse (opioid use disorder diagnosis while possessing an opioid prescription), opioid misuse (a composite indicator of number of opioid prescribers, number of pharmacies, and days supplied), and dose exposure during opioid treatment episodes. Results: A total of 372,347 Medicaid enrollees with 583,013 new opioid treatment episodes were included in the cohort. Opioid overdose was higher among those with abuse (1.5%) compared with those without (0.2%, P<0.001). Overdose was higher among those with probable (1.8%) and possible (0.9%) misuse compared with those without (0.2%, P<0.001). Abuse [adjusted rate ratio (ARR), 1.52; 95% confidence interval (CI), 1.10-2.10), probable misuse (ARR, 1.98; 95% CI, 1.46-2.67), and possible misuse (ARR, 1.76; 95% CI, 1.48-2.09) were associated with significantly more events of opioid medication overdose compared with those without. Conclusions: Claims-based measures can be used by health systems to identify individuals at-risk of overdose who can be targeted for restrictions on opioid prescribing, dispensing, or referral to treatment.

AB - Background: Health systems may play an important role in identification of patients at-risk of opioid medication overdose. However, standard measures for identifying overdose risk in administrative data do not exist. Objective: Examine the association between opioid medication overdose and 2 validated measures of nonmedical use of prescription opioids within claims data. Research Design: A longitudinal retrospective cohort study that estimated associations between overdose and nonmedical use. Subjects: Adult Pennsylvania Medicaid program 2007-2012 patients initiating opioid treatment who were: nondual eligible, without cancer diagnosis, and not in long-term care facilities or receiving hospice. Measures: Overdose (International Classification of Disease, ninth edition, prescription opioid poisonings codes), opioid abuse (opioid use disorder diagnosis while possessing an opioid prescription), opioid misuse (a composite indicator of number of opioid prescribers, number of pharmacies, and days supplied), and dose exposure during opioid treatment episodes. Results: A total of 372,347 Medicaid enrollees with 583,013 new opioid treatment episodes were included in the cohort. Opioid overdose was higher among those with abuse (1.5%) compared with those without (0.2%, P<0.001). Overdose was higher among those with probable (1.8%) and possible (0.9%) misuse compared with those without (0.2%, P<0.001). Abuse [adjusted rate ratio (ARR), 1.52; 95% confidence interval (CI), 1.10-2.10), probable misuse (ARR, 1.98; 95% CI, 1.46-2.67), and possible misuse (ARR, 1.76; 95% CI, 1.48-2.09) were associated with significantly more events of opioid medication overdose compared with those without. Conclusions: Claims-based measures can be used by health systems to identify individuals at-risk of overdose who can be targeted for restrictions on opioid prescribing, dispensing, or referral to treatment.

KW - health claims

KW - opioid medication misuse and abuse

KW - opioid medication overdose

UR - http://www.scopus.com/inward/record.url?scp=85012914598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012914598&partnerID=8YFLogxK

U2 - 10.1097/MLR.0000000000000676

DO - 10.1097/MLR.0000000000000676

M3 - Article

C2 - 27984346

AN - SCOPUS:85012914598

VL - 55

SP - 291

EP - 298

JO - Medical Care

JF - Medical Care

SN - 0025-7079

IS - 3

ER -